Therefore, our study focuses on activated B cells during CSR, proposing that ablation of MCT1 shifts glucose metabolism from glycolysis to OXPHOS, reducing AID expression by regulating H3K27 acetylation, which, in turn, hinders CSR and participates in SLE. This evidence concerns the gene SLC16A1 and systemic lupus erythematosus.